After multiple clinical failures, it’s finally the end of the road for Merck’s TIGIT program.
The company is dropping development of its anti-TIGIT candidate vibostolimab …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Credit: Shutterstock Epilepsy is a chronic neurological condition characterised by recurring seizures, involuntary movements affecting the body. Idiopathic generalised epilepsy is the most common form,
Welcome to Culture Clinic, MedPage Today‘s collaboration with Northwell Health to offer a healthcare professional’s take on the latest viral medical topics. Videos of health
Gene therapy for hemophilia B allowed almost three-fourths of patients to discontinue prophylactic factor IX therapy with no increase in bleeding, results of the pivotal